The effect of sera of patients with systemic lupus erythematosus on artificial immune complexes.

A. Bányai, G. Szabó, J. Csongor, I. Sonkoly, G. Szegedi

Research output: Article

Abstract

The solubilization of artificial immune complexes mediated by complements has been well-known since 1975. It is known that the process is bound to the integrity of the alternative complement pathway. The phenomenon of solubilization can be used in the investigation of the function of the complement system. We have studied the solubilization of artificial complexes containing BSA and 125I labelled anti-BSA on the effect of sera of healthy subjects and those of patients suffering from SLE. We have observed that the solubilization capacity of SLE sera is significantly lower than that of healthy persons. The decrease is the most distinct at the time of the activity of the disease.

Original languageEnglish
Pages (from-to)51-57
Number of pages7
JournalActa Medica Hungarica
Volume42
Issue number1-2
Publication statusPublished - 1985

Fingerprint

Antigen-Antibody Complex
Systemic Lupus Erythematosus
Alternative Complement Pathway
Serum
Healthy Volunteers

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The effect of sera of patients with systemic lupus erythematosus on artificial immune complexes. / Bányai, A.; Szabó, G.; Csongor, J.; Sonkoly, I.; Szegedi, G.

In: Acta Medica Hungarica, Vol. 42, No. 1-2, 1985, p. 51-57.

Research output: Article

Bányai, A. ; Szabó, G. ; Csongor, J. ; Sonkoly, I. ; Szegedi, G. / The effect of sera of patients with systemic lupus erythematosus on artificial immune complexes. In: Acta Medica Hungarica. 1985 ; Vol. 42, No. 1-2. pp. 51-57.
@article{55be1cee06ab4b8283c6db9cf2e25543,
title = "The effect of sera of patients with systemic lupus erythematosus on artificial immune complexes.",
abstract = "The solubilization of artificial immune complexes mediated by complements has been well-known since 1975. It is known that the process is bound to the integrity of the alternative complement pathway. The phenomenon of solubilization can be used in the investigation of the function of the complement system. We have studied the solubilization of artificial complexes containing BSA and 125I labelled anti-BSA on the effect of sera of healthy subjects and those of patients suffering from SLE. We have observed that the solubilization capacity of SLE sera is significantly lower than that of healthy persons. The decrease is the most distinct at the time of the activity of the disease.",
author = "A. B{\'a}nyai and G. Szab{\'o} and J. Csongor and I. Sonkoly and G. Szegedi",
year = "1985",
language = "English",
volume = "42",
pages = "51--57",
journal = "Acta Medica Hungarica",
issn = "0236-5286",
publisher = "Akademiai Kiado",
number = "1-2",

}

TY - JOUR

T1 - The effect of sera of patients with systemic lupus erythematosus on artificial immune complexes.

AU - Bányai, A.

AU - Szabó, G.

AU - Csongor, J.

AU - Sonkoly, I.

AU - Szegedi, G.

PY - 1985

Y1 - 1985

N2 - The solubilization of artificial immune complexes mediated by complements has been well-known since 1975. It is known that the process is bound to the integrity of the alternative complement pathway. The phenomenon of solubilization can be used in the investigation of the function of the complement system. We have studied the solubilization of artificial complexes containing BSA and 125I labelled anti-BSA on the effect of sera of healthy subjects and those of patients suffering from SLE. We have observed that the solubilization capacity of SLE sera is significantly lower than that of healthy persons. The decrease is the most distinct at the time of the activity of the disease.

AB - The solubilization of artificial immune complexes mediated by complements has been well-known since 1975. It is known that the process is bound to the integrity of the alternative complement pathway. The phenomenon of solubilization can be used in the investigation of the function of the complement system. We have studied the solubilization of artificial complexes containing BSA and 125I labelled anti-BSA on the effect of sera of healthy subjects and those of patients suffering from SLE. We have observed that the solubilization capacity of SLE sera is significantly lower than that of healthy persons. The decrease is the most distinct at the time of the activity of the disease.

UR - http://www.scopus.com/inward/record.url?scp=0021778198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021778198&partnerID=8YFLogxK

M3 - Article

C2 - 4034337

AN - SCOPUS:0021778198

VL - 42

SP - 51

EP - 57

JO - Acta Medica Hungarica

JF - Acta Medica Hungarica

SN - 0236-5286

IS - 1-2

ER -